Xylem Inc. (XYL)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Xylem Inc. (“Xylem” or “the Company”) (NYSE: XYL). Investors who purchased Xylem securities are encouraged to obtain additional information and assist the investigation.  

The investigation concerns whether Xylem has violated federal securities laws. 

Investigation Details: 

On August 9, 2023, Spruce Point Capital Management issued a report on Xylem entitled “A Leak In The Bull Case” (the “Spruce Point Report”).  The Spruce Point Report expressed “concerns about the accuracy of the Company’s cash liquidity given findings of two sets of financial statements and its ability to meet Wall Street’s aggressive financial expectations.”  The Spruce Point Report also noted that Evoqua, a company acquired by Xylem in May 2023, “was recently charged with revenue accounting fraud by the SEC and has been under federal investigation by the U.S. Attorney’s office.”  On this news, Xylem’s stock price fell $2.82 per share, or 2.68%, to close at $102.33 per share on August 9, 2023. 

What’s Next? 

If you are aware of any facts relating to this investigation or purchased Xylem securities, you can assist this investigation. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.   

Why Bronstein, Gewirtz & Grossman: 

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.  Our firm has recovered hundreds of millions of dollars for investors nationwide.  

Attorney advertising. Prior results do not guarantee similar outcomes.


Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]